Abstract
Introduction: Progressive osseous heteroplasia (POH) is a condition of invasive heterotopic ossification. Reports of patients with mild POH with Albright hereditary osteodystrophy (AHO), specifically pseudohypoparathyroidism type Ia (PHP Ia) with hormonal resistance, suggest the possibility of a common molecular basis. GNAS has been implicated to account for overlapping features of POH and PHP Ia.
Case 1: A 4-year-old boy with obesity, speech delay, and expanding subcutaneous masses on buttock/forearm. Physical exam revealed round facies and brachydactyly. Blood tests showed normal Ca, P, Mg, 25-OH vitamin D levels but elevated parathyroid hormone (PTH) and thyroid-stimulating hormone (TSH). Abdominal computed tomography (CT) showed areas with calcifications in the subcutaneous tissue, fat, and muscle. Pathology of excised tissue revealed ossifications. Genomic study revealed no GNAS mutation. He had POH and PHP Ia.
Case 2: A 3-year-old boy with painful ossifications in the left lower extremity. Lab tests were notable for elevated PTH and high-normal TSH. The CT-scan showed subcutaneous/intramuscular calcifications. Genetic testing showed GNAS mutation in exon 12 [c.1024C>T (R342X)]. Patient had POH and PHP Ia.
Case 3: A 9-year-old boy with knee pain and subcutaneous ossifications in back and upper/lower extremity, causing significantly limited joint mobility. Lab tests were normal. The CT-scan showed areas corresponding to subcutaneous/intramuscular ossifications throughout torso and extremities, consistent with POH. There was no GNAS mutation.
Conclusions: Patients with heterotopic ossifications present with a wide spectrum of disease. Although GNAS-based mutations have been postulated to account for overlapping features of AHO and POH, normal DNA studies in certain patients with POH/AHO suggest that there may exist other molecular/epigenetic mechanisms explaining their overlapping features.
Acknowledgments
Work by EG-L was funded by U.S. Food and Drug Administration Orphan Products Development Grants R01-FD-R-002568 and R01-FD-R-003409.
Conflict of interest disclosure: Authors M. Lin, N. Numbenjapon, E. Germain-Lee, and P. Pitukcheewanont declare that they have no conflict of interest.
Ethical standards: Details that might disclose the identity of patients included in the article were omitted.
References
1. Kaplan FS, Craver R, MacEwen GD, Gannon FH, Finkel G, et al. Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J Bone Joint Surg Am 1994;76:425–36.10.2106/00004623-199403000-00013Search in Google Scholar
2. Urtizberea JA, Testart H, Cartault F, Boccon-Gibod L, Le MM, et al. Progressive osseous heteroplasia. Report of a family. J Bone Joint Surg Br 1998;80:768–71.10.1302/0301-620X.80B5.0800768Search in Google Scholar
3. Cairns DM, Pignolo RJ, Uchimura T, Brennan TA, Lindborg CM, et al. Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia. J Clin Invest 2013;123:3624–33.10.1172/JCI69746Search in Google Scholar PubMed PubMed Central
4. Kaplan FS, Shore EM. Progressive osseous heteroplasia. J Bone Miner Res 2000;15:2084–94.10.1359/jbmr.2000.15.11.2084Search in Google Scholar PubMed
5. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg 2004;12:116–25.10.5435/00124635-200403000-00007Search in Google Scholar PubMed
6. Shore EM, Ahn J, Jan de BS, Li M, Xu M, et al. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med 2002;346:99–106.10.1056/NEJMoa011262Search in Google Scholar PubMed
7. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001;22:675–5.Search in Google Scholar
8. Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab 2007;92:1073–9.10.1210/jc.2006-1497Search in Google Scholar PubMed
9. Kaplan FS. Skin and bones. Arch Dermatol 1996;132:815–8.10.1001/archderm.1996.03890310101015Search in Google Scholar
10. Gelfand IM, Hub RS, Shore EM, Kaplan FS, Dimeglio LA. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report. Bone 2007;40:1425–8.10.1016/j.bone.2006.12.058Search in Google Scholar PubMed
11. Schimmel RJ, Pasmans SG, Xu M, Stadhouders-Keet SA, Shore EM, et al. GNAS-associated disorders of cutaneous ossification: two different clinical presentations. Bone 2010;46:868–72.10.1016/j.bone.2009.11.001Search in Google Scholar PubMed PubMed Central
12. Eddy MC, Jan De Beur SM, Yandow SM, McAlister WH, Shore EM, et al. Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification. J Bone Miner Res 2000;15:2074–83.10.1359/jbmr.2000.15.11.2074Search in Google Scholar
13. Faust RA, Shore EM, Stevens CE, Xu M, Shah S, et al. Progressive osseous heteroplasia in the face of a child. Am J Med Genet A 2003;118A:71–5.10.1002/ajmg.a.10170Search in Google Scholar
14. Ahmed SF, Dixon PH, Bonthron DT, Stirling HF, Barr DG, et al. GNAS1 mutational analysis in pseudohypoparathyroidism. Clin Endocrinol (Oxf) 1998;49:525–31.10.1046/j.1365-2265.1997.1100922.x-i1Search in Google Scholar
15. Yeh GL, Mathur S, Wivel A, Li M, Gannon FH, et al. GNAS1 mutation and Cbfa1 misexpression in a child with severe congenital platelike osteoma cutis. J Bone Miner Res 2000;15:2063–73.10.1359/jbmr.2000.15.11.2063Search in Google Scholar
16. Jan de Beur SM, Levine LM. Pseudohypoparathyroidism: clinical, biochemical, and molecular features. In: Bilezikian JP, editor. The parathyroids: basic and clinical concepts. San Diego, CA: Academic Press, 2001:807–25.Search in Google Scholar
17. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 1990;322:1412–9.10.1056/NEJM199005173222002Search in Google Scholar
18. Shields MB, Buckley E, Klintworth GK, Thresher R. Axenfeld-Rieger syndrome. A spectrum of developmental disorders. Surv Ophthalmol 1985;29:387–409.10.1016/0039-6257(85)90205-XSearch in Google Scholar
19. Tresserra L, Tresserra F, Grases PJ, Badosa J, Tresserra M. Congenital plate-like osteoma cutis of the forehead: an atypical presentation form. J Craniomaxillofac Surg 1998;26:102–6.10.1016/S1010-5182(98)80048-6Search in Google Scholar
20. Hou JW. Progressive osseous heteroplasia controlled by intravenous administration of pamidronate. Am J Med Genet A 2006;140:910–3.10.1002/ajmg.a.31200Search in Google Scholar PubMed
21. Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A 2008;146A:1788–96.10.1002/ajmg.a.32346Search in Google Scholar PubMed PubMed Central
22. Lebrun M, Richard N, Abeguile G, David A, Coeslier DA, et al. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans. J Clin Endocrinol Metab 2010;95:3028–38.10.1210/jc.2009-1451Search in Google Scholar PubMed
23. Hayward BE, Moran V, Strain L, Bonthron DT. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998;95:15475–80.10.1073/pnas.95.26.15475Search in Google Scholar
24. Levine MA, Downs RW, Jr., Moses AM, Breslau NA, Marx SJ, et al. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983;74:545–56.10.1016/0002-9343(83)91008-2Search in Google Scholar
25. Levine MA, Jap TS, Mauseth RS, Downs RW, Spiegel AM. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright’s hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 1986;62:497–502.10.1210/jcem-62-3-497Search in Google Scholar
26. Brickman AS, Carlson HE, Levin SR. Responses to glucagon infusion in pseudohypoparathyroidism. J Clin Endocrinol Metab 1986;63:1354–60.10.1210/jcem-63-6-1354Search in Google Scholar
27. Germain-Lee EL, Groman J, Crane JL, Jan De Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003;88:4059–69.10.1210/jc.2003-030028Search in Google Scholar
28. Germain-Lee EL. Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a. Pediatr Endocrinol Rev 2006;3(Suppl 2):318–27.Search in Google Scholar
29. Mantovani G, Maghnie M, Weber G, De ME, Brunelli V, et al. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 2003;88:4070–4.10.1210/jc.2002-022028Search in Google Scholar
30. Germain-Lee EL, Ding CL, Deng Z, Crane JL, Saji M, et al. Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 2002;296:67–72.10.1016/S0006-291X(02)00833-1Search in Google Scholar
31. Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, et al. A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology 2005;146:4697–709.10.1210/en.2005-0681Search in Google Scholar PubMed
32. Yu S, Yu D, Lee E, Eckhaus M, Lee R, et al. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci USA 1998;95:8715–20.10.1073/pnas.95.15.8715Search in Google Scholar PubMed PubMed Central
33. Huso DL, Edie S, Levine MA, Schwindinger W, Wang Y, et al. Heterotopic ossifications in a mouse model of Albright hereditary osteodystrophy. PLoS One 2011;6:e21755.10.1371/journal.pone.0021755Search in Google Scholar PubMed PubMed Central
34. Pignolo RJ, Xu M, Russell E, Richardson A, Kaplan J. et al. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. J Bone Miner Res 2011;26:2647–55.10.1002/jbmr.481Search in Google Scholar PubMed PubMed Central
35. Plagge A, Kelsey G, Germain-Lee EL. Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse. J Endocrinol 2008;196:193–214.10.1677/JOE-07-0544Search in Google Scholar PubMed
36. Cortes W, Gosain AK. Recurrent ectopic calcification involving the maxillofacial skeleton: a potential harbinger of Albright’s osteodystrophy. J Craniofac Surg 2006;17:21–7.10.1097/01.scs.0000188906.42225.39Search in Google Scholar PubMed
©2015 by De Gruyter
